Digital Biomarkers and Alzheimer’s Research: Q&A With Liam Kaufman, VP of Clinical Sciences at Cambridge Cognition

Kaufman discusses the ways the digital biomarkers are improving Alzheimer’s research by directly tackling some of the unique challenges that researchers face.